Myocardial Ischemia
📧 Sign up to get email alerts when something new happens for Myocardial Ischemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia [Phase 2]
Phase 2 safety and feasibility trial of adipose-derived regenerative cells for chronic myocardial ischemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Cardiac Magnetic Resonance Utilities in the Evaluation of Ischemic Heart Disease
A completed clinical trial evaluating the utility of cardiac magnetic resonance imaging in the evaluation of ischemic heart disease.
-
CLINICAL_TRIALS research · 2016-08-30Clinical Trial Update: BIOFLOW-III All-comers Orsiro Safety and Performance Registry
This is a clinical trial update for the BIOFLOW-III Orsiro safety and performance registry sponsored by Biotronik, involving patients with c…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT) [Phase 4]
Phase 4 post-approval randomized trial in China evaluating the XIENCE V Everolimus-eluting coronary stent system was completed, with results…
-
CLINICAL_TRIALS research · 2016-08-18Clinical Trial Update: BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
Post-market BMX Alpha Registry is monitoring outcomes in patients with coronary disease and ischemic conditions after BioMatrix Alpha stent …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [Phase 3]
Phase 3 ALLHAT trial update reporting completed results evaluating antihypertensive therapies (chlorthalidone, lisinopril, amlodipine, and d…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Whitehall II - Social and Occupational Influences On Health and Illness
The Whitehall II study, sponsored by NHLBI, is a completed observational trial examining how social and occupational factors influence cardi…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
Post-marketing surveillance update for XIENCE PRIME in Japan; study completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Beta-Blocker Heart Attack Trial (BHAT) [Phase 3]
This update reports the completion of the Phase 3 Beta-Blocker Heart Attack Trial (BHAT), a study of beta-blocker therapy in patients after …
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Multicenter Investigation of Limitation of Infarct Size (MILIS) [Phase 3]
Phase 3 multicenter trial MILIS evaluating strategies to limit infarct size in myocardial infarction has completed enrollment and is reporte…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Women's Angiographic Vitamin and Estrogen Trial (WAVE) [Phase 3]
Phase 3 trial in postmenopausal women evaluating estrogen plus a vitamin treatment for cardiovascular outcomes has completed.
-
CLINICAL_TRIALS withdrawal · 2016-06-29Clinical Trial Update: The eSVS® Mesh Post-Marketing Trial [NA]
The post-marketing trial of the eSVS Mesh has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort [Phase 4]
Phase 4 clinical trial update for XIENCE V USA Dual Antiplatelet Therapy cohort; study completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent [Phase 2]
Phase 2 safety and efficacy study of the FORTITUDE bioresorbable drug-eluting coronary stent by Amaranth Medical is ongoing.
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent [Phase 2]
Phase 2 safety and efficacy study of Amaranth Medical's APTITUDE bioresorbable drug-eluting coronary stent for coronary artery disease and m…
-
CLINICAL_TRIALS research · 2016-06-08Clinical Trial Update: Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent [Phase 2]
This is a Phase 2 feasibility study of the FORTITUDE bioresorbable drug-eluting coronary stent by Amaranth Medical, with the trial status cu…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Bypass Angioplasty Revascularization Investigation (BARI) [Phase 3]
Completion update of the Phase 3 BARI trial comparing bypass surgery versus angioplasty in patients with coronary disease, highlighting the …
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Postmenopausal Estrogen/Progestin Interventions (PEPI) [Phase 3]
Phase 3 PEPI trial completed. The study evaluated postmenopausal estrogen/progestin interventions for effects on bone health and cardiovascu…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease [NA]
Dan-NICAD is a Danish study evaluating non-invasive diagnostic testing in coronary artery disease; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Racial Differences in the Coronary Microcirculation
The NHLBI-sponsored trial evaluating racial differences in the coronary microcirculation has completed; the snippet does not provide specifi…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio)
A Kuopio-based clinical trial funded by NHLBI investigating psychosocial mechanisms related to ischemic heart disease has completed. The stu…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Mindfulness-Based Stress Reduction and Myocardial Ischemia [NA]
A completed clinical trial evaluated mindfulness-based stress reduction in individuals with arteriosclerosis and myocardial ischemia.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Cardiac Arrhythmia Suppression Trial (CAST) [Phase 3]
The CAST trial, a Phase 3 cardiac arrhythmia study, has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Studies of Left Ventricular Dysfunction (SOLVD) [Phase 3]
The SOLVD studies (Studies of Left Ventricular Dysfunction) Phase 3 program has completed, evaluating therapies for left ventricular dysfunc…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE) [Phase 3]
Phase 3 PEACE trial evaluated whether ACE inhibitor therapy with trandolapril reduces cardiovascular events in patients with stable coronary…